Enfusion Historical Financial Ratios
| ENFN Stock | USD 10.56 0.22 2.13% |
Enfusion is recently reporting on over 97 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 16.74 or Days Sales Outstanding of 46.78 will help investors to properly organize and evaluate Enfusion financial condition quickly.
Enfusion |
About Enfusion Financial Ratios Analysis
EnfusionFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Enfusion investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Enfusion financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Enfusion history.
Enfusion Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Enfusion stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Enfusion sales, a figure that is much harder to manipulate than other Enfusion multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Enfusion dividend as a percentage of Enfusion stock price. Enfusion dividend yield is a measure of Enfusion stock productivity, which can be interpreted as interest rate earned on an Enfusion investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Enfusion's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Enfusion current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.At this time, Enfusion's Free Cash Flow Per Share is very stable compared to the past year. As of the 11th of December 2024, ROIC is likely to grow to 0.17, while Price To Sales Ratio is likely to drop 4.66.
| 2021 | 2023 | 2024 (projected) | Dividend Yield | 0.002391 | 0.002749 | 0.003434 | Price To Sales Ratio | 12.29 | 4.9 | 4.66 |
Enfusion fundamentals Correlations
Click cells to compare fundamentals
Enfusion Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Enfusion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enfusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will appreciate offsetting losses from the drop in the long position's value.Moving together with Enfusion Stock
| 0.67 | U | Unity Software Aggressive Push | PairCorr |
| 0.8 | DJCO | Daily Journal Corp | PairCorr |
| 0.84 | AI | C3 Ai Inc Tech Boost | PairCorr |
| 0.81 | BL | Blackline | PairCorr |
| 0.62 | DT | Dynatrace Holdings LLC | PairCorr |
The ability to find closely correlated positions to Enfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enfusion to buy it.
The correlation of Enfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enfusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enfusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enfusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share 2.155 | Quarterly Revenue Growth 0.154 | Return On Assets 0.0592 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.